Novel Anti Angptl3 Antibodies Suitable For High Concentration

Novel Anti Angptl3 Antibodies Suitable For High Concentration Compositions And Subcutaneous Administration

Abstract: The present invention relates to novel monovalent anti-ANGPTL3 antibodies for use in medicine and in particular for lowering of plasma triglycerides levels in patients in need thereof, such as patients suffering from or at risk of hypertriglyceridemia and/or cardiovascular disease, such as atherosclerotic cardiovascular disease (ASCVD) as well as pharmaceutical compositions suitable for subcutaneous administration and kits comprising such compounds and compositions.

Patent Information

Application #

Filing Date

27 November 2024

Publication Number

48/2024

Publication Type

INA

Invention Field

CHEMICAL

Status

Email

Parent Application

Applicants

NOVO NORDISK A/S

Novo Allé 2880 Bagsværd

Inventors

1. HENRIKSEN, Anette

Novo Alle 1 2880 Bagsværd

2. KROGH, Thomas Nylandsted

Novo Alle 1 2880 Bagsværd

3. GREISEN, Per j.

Novo Alle 1 2880 Bagsværd

4. EGEBJERG, Thomas

Novo Alle 1 2880 Bagsværd

Specification

Documents

Application Documents

#	Name	Date
1	202447092548-STATEMENT OF UNDERTAKING (FORM 3) [27-11-2024(online)].pdf	2024-11-27
3	202447092548-Sequence Listing in PDF [27-11-2024(online)].pdf	2024-11-27
4	202447092548-PROOF OF RIGHT [27-11-2024(online)].pdf	2024-11-27
5	202447092548-PRIORITY DOCUMENTS [27-11-2024(online)].pdf	2024-11-27
6	202447092548-POWER OF AUTHORITY [27-11-2024(online)].pdf	2024-11-27
7	202447092548-FORM 1 [27-11-2024(online)].pdf	2024-11-27
8	202447092548-DRAWINGS [27-11-2024(online)].pdf	2024-11-27
9	202447092548-DECLARATION OF INVENTORSHIP (FORM 5) [27-11-2024(online)].pdf	2024-11-27
10	202447092548-COMPLETE SPECIFICATION [27-11-2024(online)].pdf	2024-11-27
11	202447092548-FORM 18 [28-11-2024(online)].pdf	2024-11-28
12	202447092548-FORM 3 [26-05-2025(online)].pdf	2025-05-26